Program Administration Managing Entities If Managing Entities receive funding under the IDP, they will: Approve organizations requesting to become IDP providers. To be eligible, organizations must be under contract with the regional ME. Each July, provide a list of approved IDP providers to the Department’s Office of Substance Abuse and Mental Health (SAMH). SAMH will then determine the provider line of credit. Report bulk purchases into SAMHIS. Using the EVNT (non-client specific file upload) contractors should submit a service using the IDP OCA (MH076) with the Incidental Expense covered service (28) and the actual dollar amount for the units. Ensure that agreements between IDP providers and participating pharmacies are current and executed. Ensure that IDP providers use IDP funds for individuals who meet the criteria. IDP Providers IDP providers will: Assess and enroll individuals in the IDP who meet the clinical and financial criteria established in ch.394, F.S. To meet the clinical criteria individuals: Must be a member of at least one of the Department’s priority populations; and Must not reside in a state mental health treatment facility or an inpatient community unit. To meet the financial eligibility criteria individuals: Must have a net family income that is at or below 150 percent of the Federal Poverty Income Guidelines, as published annually in the Federal Register; Must lack third-party insurance or other psychotropic medications funding sources; and Must not participate in a program where other funding sources pay for psychotropic medications. If individuals have third party insurance for psychotropic medications but were temporarily denied benefits for these medications, they may receive IDP medications until such time as eligibility is reestablished. Provide information to individuals regarding adverse effects, side effects, possible allergic reactions, co-occurring disorders, and instructions on what to do in case of an emergency; Submit updated information to the IDP/FSH Warehouse and to the ME with the first medication order, and ensure that the following information is updated as needed: The providers’ IDP contact information including name, e-mail, and phone number;
Program Administration Managing Entities If Managing Entities receive funding under the IDP, they will: Approve organizations requesting to become IDP providers. To be eligible, organizations must be under contract with the regional ME. Each July, provide a list of approved IDP providers to the Department’s Office of Substance Abuse and Mental Health (SAMH). SAMH will then determine the provider line of credit. Report bulk purchases into SAMHIS. Using the EVNT (non-client specific file upload) contractors should submit a service using the IDP OCA (MH076) with the Incidental Expense covered service (28) and the actual dollar amount for the units. Ensure that agreements between IDP providers and participating pharmacies are current and executed. Ensure that IDP providers use IDP funds for individuals who meet the criteria. IDP Providers IDP providers will: Assess and enroll individuals in the IDP who meet the clinical and financial criteria established in ch.394, F.S. To meet the clinical criteria individuals: Must be a member of at least one of the Department’s priority populations; and Must not reside in a state mental health treatment facility or an inpatient community unit. To meet the financial eligibility criteria individuals: Must have a net family income that is at or below 150 percent of the Federal Poverty Income Guidelines, as published annually in the Federal Register; Must lack third-party insurance or other psychotropic medications funding sources; and Must not participate in a program where other funding sources pay for psychotropic medications. If individuals have third party insurance for psychotropic medications but were temporarily denied benefits for these medications, they may receive IDP medications until such time as eligibility is reestablished. Provide information to individuals regarding adverse effects, side effects, possible allergic reactions, co-occurring disorders, and instructions on what to do in case of an emergency; Submit updated information to the IDP/FSH Warehouse and to the ME with the first medication order, and ensure that the following information is updated as needed: The providers’ IDP contact information including name, e-mail, and phone number;
Guidance%2013%20IDP%202016%2007%2001.docx